Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

½Å»ý¾Æ ´ãÁóÁ¤Ã¼ÁõÀÇ ¿øÀÎÁúȯ ¹× Àå±âÃßÀû ¿¹ÈÄÀÎÀÚ¿¡ °üÇÑ °íÂû Evaluation of the Underlying Etiology and Long-Term Prognostic Factors in Neonatal Cholestasis

´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸÁö 1999³â 2±Ç 1È£ p.46 ~ 58
±è°æ¸ð, ¼­Á¤±â,
¼Ò¼Ó »ó¼¼Á¤º¸
±è°æ¸ð ( Kim Kyung-Mo ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç

¼­Á¤±â ( Seo Jeong-Kee ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç

Abstract

¸ñÀû : ½Å»ý¾Æ ´ãÁóÁ¤Ã¼ÁõÀº ¼Ò¾Æ°ú ¼ÒÈ­±â ¿µ¿ª¿¡¼­ Áß¿äÇÑ ÁúȯÀÇ ÇϳªÀÓ¿¡µµ ºÒ±¸ÇÏ°í
¿øÀÎ Áúȯ ¹× Àå±âÃßÀû °íÂû¿¡ ´ëÇÑ ±¹³»ÀÇ º¸°í°¡ µå¹® ½ÇÁ¤ÀÌ´Ù. µû¶ó¼­ ÀúÀÚµéÀº ½Å»ý¾Æ
´ãÁóÁ¤Ã¼ÁõÀÇ ¿øÀÎ ¹× ÃßÀûÁ¶»ç½ÃÀÇ ÇÕº´Áõ µîÀÇ ÀÓ»óÀû °íÂû°ú ÇÔ²² ¿¹ÈÄÀÎÀÚ¸¦ ºÐ¼®ÇÏ¿©
½Å»ý¾Æ ´ãÁóÁ¤Ã¼Áõ ȯ¾ÆÀÇ Áø·á¿¡ µµ¿òÀ» ÁÖ°íÀÚ º» ¿¬±¸¸¦ ½ÃÇàÇÏ¿´´Ù.

¹æ¹ý : 1981³âºÎÅÍ 1992³â±îÁö 12³â°£ ½Å»ý¾Æ ȤÀº Ãʱ⠿µ¾Æ±â¿¡ ¹ß»ýÇÑ ´ãÁóÁ¤Ã¼ÁõÀ¸·Î
¼­¿ï´ëÇб³ ¾î¸°À̺´¿ø ¼Ò¾Æ°ú¿¡ ÀÔ¿øÇÏ¿´´ø 190¸íÀ» ´ë»óÀ¸·Î ÇÏ¿´´Ù. ´ãÁóÁ¤Ã¼ÁõÀÇ ¿øÀÎ
Áúȯ, ÃßÀûÁ¶»ç½Ã¿¡ °üÂûµÈ ÇÕº´Áõ ¹× »çÀÎ, Ư¹ß¼º½Å»ý¾Æ°£¿°°ú ´ãµµÆó¼âÁõÀÇ ÃʱâÀÇ ÀÓ»ó
Àû Â÷ÀÌÁ¡, ¿¹ÈÄ ¹× ¿¹ÈÄÀÎÀÚ¸¦ ºÐ¼®ÇÏ¿´´Ù.

°á°ú:
1) ´ãÁóÁ¤Ã¼ÁõÀÇ ¿øÀÎÁúȯÀº 190¸í¿¡¼­ ½Å»ý¾Æ °£¿°ÀÌ 101·Ê(53%), °£¿Ü´ãµµ°è ÁúȯÀÌ 84
·Ê(44%), °£³»´ãµµÇü¼ººÎÀüÁõÀÌ 5·Ê(3%)À̾ú´Ù. ½Å»ý¾Æ°£¿°Àº Ư¹ß¼º½Å»ý¾Æ°£¿°ÀÌ 77·Ê
(41%), °¨¿°¼º ½Å»ý¾Æ °£¿°ÀÌ 24·Ê(12%)À̾ú°í, °£¿Ü´ãµµÁúȯÀº ´ãµµÆó¼âÁõÀÌ 79·Ê(41%),
ÃѼö´ã°ü³¶ÀÌ 5·Ê(3%)À̾ú´Ù.
2) ÃßÀûÁ¶»ç½Ã¿¡ °üÂûµÈ ÁÖ¿äÇÑ ÀÓ»óÀû ¹®Á¦Á¡Àº Áö¼ÓÀûÀÎ °í¿­, À§Àå°üÃâÇ÷, °£¼ºÈ¥¼ö,
º¹¼ö µîÀ̾ú´Ù.
3) ´ãµµÆó¼âÁõ ȯ¾Æ¿¡¼­ Áö¼ÓÀûÀÎ °í¿­ÀÇ ¿øÀÎÀº »óÇ༺´ã°ü¿°, ȤÀº line-related sepsis
°¡ 58%À̾ú°í, Æä·ÅÀÌ 15%, ¿ä·Î°¨¿°ÀÌ 8%, »ó±âµµ °¨¿°ÀÌ 7%À̾ú´Ù.
4) »óÇ༺´ã°ü¿° ȤÀº line related sepsisÀÇ ¿øÀαÕÀº Escherichia coli°¡ 28%·Î °¡Àå ºóµµ
°¡ ¸¹¾Ò°í, Coagulase negative staphylococcus°¡ 14%, Streptococcus pneumoniae,
Klebsiela pneumoniae°¡ °¢°¢ 10%, Enterococcus°¡ 6%, Candida albicans°¡ 4%À̾ú´Ù.
5) ÁÖ¿äÇÑ »çÀÎÀº °£¼ºÈ¥¼ö¿Í À§Àå°üÃâÇ÷À̾ú´Ù.
6) Ư¹ß¼º½Å»ý¾Æ°£¿°Àº 71%, °¨¿°¼º ½Å»ý¾Æ°£¿°Àº 75%ÀÇ È¯¾Æ¿¡¼­ ȸº¹µÇ¾úÀ¸¸ç, ´ëºÎºÐ
»ýÈÄ 12°³¿ù À̳», ÁÖ·Î 6°³¿ù À̳»¿¡ ȸº¹µÇ¾ú´Ù. ¹Ì¼÷¾Æ, ÃʱâÀÇ °£Á¾´ë°¡ ÀÛÀº °æ¿ì, Ãʱâ
¾ËºÎ¹ÎÄ¡ ³ôÀº °æ¿ì, ÄÝ·¹½ºÅ×·ÑÄ¡, ¥ã-GTÄ¡, ºô¸®·çºóÄ¡ ¹× ASTÄ¡°¡ ³·Àº °æ¿ì¿¡¼­ ¿¹ÈÄ
°¡ ¾çÈ£ÇÏ¿´´Ù.
7) ´ãµµÆó¼âÁõ ȯ¾ÆÀÇ Kasai¼ö¼úÈÄÀÇ 5³â »ýÁ¸À²Àº 40%À̾ú°í »ç¸ÁÀÇ ´ëºÎºÐÀº 12°³¿ù
À̳»¿¡ °üÂûµÇ¾ú´Ù. °¡Àå Áß¿äÇÑ ¿¹ÈÄÀÎÀÚ´Â ¼ö¼ú½Ã±âÀ̾ú°í ¼ö¼ú½Ã±â°¡ 12ÁÖ ÀÌÀüÀÎ 49%
°¡ ¾çÈ£ÇÑ ¿¹Èĸ¦ º¸ÀÎ ¹Ý¸é¿¡, 12ÁÖ ÀÌÈÄÀÎ °æ¿ì´Â 12%À̾ú´Ù.
8) ´ãÁóÁ¤Ã¼ÁõÀÇ Ãʱâ ÀÓ»ó¼Ò°ßÁß °¡Àå Áß¿äÇÑ ¿¹ÈÄÀÎÀÚ´Â ¿øÀÎÁúȯÀ̾ú´Ù.
9) Ư¹ß¼º½Å»ý¾Æ°£¿°°ú ´ãµµÆó¼âÁõ »çÀÌ¿¡¼­ Â÷À̸¦ º¸ÀÎ ÀÓ»ó¼Ò°ßÀº ¼ºº°, Á¦Å¿¬·É, ÄÝ
·¹½ºÅ׸¦Ä¡ ¹× ¥ã-GTÄ¡ À̾ú´Ù. Ư¹ß¼º½Å»ý¾Æ°£¿°Àº ³²¾Æ, ¹Ì¼÷¾Æ¿¡½Ã È£¹ßÇÏ¿´°í, ³·Àº ÄÝ
·¹½ºÅ×·ÑÄ¡ ¹× ¥ã-GTÄ¡¸¦ º¸¿´´Ù.

°á·Ð : ¿ì¸®³ª¶ó¿¡¼­ ½Å»ý¾Æ ´ãÁóÁ¤Ã¼ÁõÀÇ ÈçÇÑ ¿øÀÎÀ¸·Î´Â ´ãµµÆó¼âÁõ°ú Ư¹ß¼º½Å»ý¾Æ°£
¿°ÀÇ ºóµµ°¡ °¡Àå ³ô¾Ò°í, ÀÌ¿Ü¿¡ °¨¿°¼º ½Å»ý¾Æ °£¿°, ÃѼö´ã°ü³¶, Alagille ÁõÈıº µîÀ̾ú
À¸¸ç, À¯Àü¼º, ´ë»ç¼ºÁúȯÀº °üÂûµÇÁö ¾Ê¾Ò´Ù. ½Å»ý¾Æ ´ãÁóÁ¤Ã¼Áõ¿¡¼­ ¿øÀÎÁúȯÀº ¿¹Èĸ¦ °á
Á¤ÇÏ´Â °¡Àå Áß¿äÇÑ ¿äÀÎÀ¸·Î ¿øÀÎÁúȯ¿¡ ´ëÇÑ ÀûÀýÇÑ Áø´ÜÀÌ ¿ä±¸µÇ¸ç, ¶ÇÇÑ »óÇ༺ ´ã°ü
¿°, Æó·Å, ÆÐÇ÷Áõ µîÀÇ °¨¿°¹®Á¦, °£¼ºÈ¥¼ö, À§Àå°ü ÃâÇ÷ µîÀº Àå±â ÃßÀû½ÃÀÇ ÀÚÁÖ ¹ß»ýÇÏ´Â
½É°¢ÇÑ ÀÓ»óÀû ¹®Á¦Á¡À¸·Î¼­ ÀÌ¿¡ ´ëÇÑ ÀûÀýÇÑ Ä¡·á´ëÃ¥ÀÌ ¿ä±¸µÈ´Ù°í ÇÏ°Ú´Ù.

Purpose : The aim of the present study was to evaluate the long-term clinical profile
including the underlying etioligy and the prognostic factors of the neonatal cholestasis.

Method : We studied the 190 infants presented with neonatal cholestasis for the last
12 years (from 1981 to 1992). The underlying causes, clinical findings and long-term
outcomes were evaluated. And the prognostic factors were also analyzed.

Result : Underlying disease were neonatal hepatitis in 101 (idiopathic in 77 and
infectious in 24), intrahepatic bile duct paucity in 5, biliary atresia in 79, choledochal
cyst in 5. Metabolic disease was not observed in this study. The important clinical
problems during follow-up were persistent high fever, gastrointestinal bleeding, hepatic
encephalopathy and ascites. The main causes of the death were hepatic encephalopathy
and gastrointestinal bleeding. While three fourth of infants with idiopathic and infectious
neonatal hepatitis recovered usually within a year, five-year survival rate for biliary
atresia was just 40%, the mortality observed usually within the first year after Kasai
operation and prognostic factor was the time of operation. Underlying disease was the
most important prognostic factor of neonatal cholestasis.

Conclusion : This study showed that most common causes of neonatal cholestasis
were biliary atresia and idiopathic neonatal hepatitis, infectious neonatal hepatitis,
choledochal cyst and Alagille syndrome, but few neonatal cholestasis of genetic or
metabolic liver disease was observed. The most important long-term prognostic factor of
neonatal cholestasis was the underlying disease.

Å°¿öµå

Neonatal cholestasis; Neonatal hepatitis; Biliary atresia; Prognosis; Prognostic factor;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS